Titan, Novartis to begin dose-related trials

TTP and partner Novartis (NVS; SWX:NOVN) will begin dose-related trials, including once-a-day dosing, of their Zomaril iloperidone dopamine and serotonin receptor antagonist to treat acute schizophren...